ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

ACHV Achieve Life Sciences Inc

4,779
-0,201 (-4,04%)
18 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Achieve Life Sciences Inc ACHV NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,201 -4,04% 4,779 23:12:24
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,97 4,76 4,97 4,78 4,98
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.6.202423:07EDGAR2Form 8-K - Current report
29.5.202414:00GLOBEAchieve Life Sciences Announces Initiation of ORCA-OL..
20.5.202423:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17.5.202420:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17.5.202414:00GLOBEAchieve Life Sciences Announces Data from Cytisinicline..
09.5.202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.5.202422:01GLOBEAchieve Life Sciences Reports Financial Results for First..
07.5.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06.5.202417:16GLOBEAchieve Life Sciences Announces Publication of Cytisinicline..
25.4.202414:00GLOBEAchieve Life Sciences to Announce First Quarter Financial..
11.4.202414:00GLOBEAchieve Life Sciences to Present at Life Science Innovation..
28.3.202421:01GLOBEAchieve Life Sciences Reports Financial Results for Fourth..
20.3.202413:00GLOBEAchieve Life Sciences Announces Data from Cytisinicline ORCA..
14.3.202413:00GLOBEAchieve Life Sciences to Announce Fourth Quarter and..
06.3.202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:41EDGAR2Form 8-K - Current report
29.2.202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29.2.202414:01GLOBEAchieve Life Sciences Reaches Agreement with the FDA on..
29.2.202414:00GLOBEAchieve Life Sciences Announces Pricing of up to $124.2..
27.2.202421:32EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29.1.202420:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202322:04EDGAR2Form 8-K - Current report
09.11.202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:00GLOBEAchieve Life Sciences Reports Financial Results for Third..
26.10.202314:00GLOBEAchieve Life Sciences to Announce Third Quarter 2023..
03.10.202314:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
11.9.202314:00GLOBEAchieve Life Sciences Announces Presentation of..
07.9.202314:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
14.8.202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202322:06EDGAR2Form 8-K - Current report
14.8.202322:00GLOBEAchieve Life Sciences Reports Financial Results for Second..
01.8.202314:00GLOBEAchieve Life Sciences to Announce Second Quarter 2023..
18.7.202314:00GLOBEAchieve Life Sciences Announces Presentation at 2023..
11.7.202317:23GLOBEAchieve Life Sciences Announces Publication of Cytisinicline..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock